Loading…
Boardwalk Elixir, LLC was cited for manufacturing and distributing e-liquid tobacco products without the required premarket authorization orders mandated by the Family Smoking Prevention and Tobacco Control Act. The FDA determined that the company's e-liquids, offered for sale through their website, qualified as "new tobacco products" under the Federal Food, Drug, and Cosmetic Act and were therefore subject to FDA jurisdiction and premarket review requirements that took effect in August 2016. The company failed to obtain the necessary marketing authorization orders before commercializing these products in the United States.